Chlamydia IgG Reactive: What That Result Changes, and What It Doesn't

Why this bacterium is so good at being invisible

Chlamydia trachomatis is, by the World Health Organization's count, the most common bacterial sexually transmitted infection on the planet, with an estimated 128.5 million new infections in 2020 among adults aged 15 to 49. And the vast majority of those people had no idea.

The CDC's case definition notes that about three quarters of infected women and about half of infected men develop no symptoms at all. When symptoms do appear, they usually show up one to three weeks after exposure, and they are easy to miss or misread: unusual discharge, a burning sensation while urinating, lower abdominal pain, bleeding between periods. Many infections simply never announce themselves.

That silence is what makes chlamydia dangerous, not dramatic. The bacteria sit in the cervix and quietly do their damage over months or years. In women, untreated infection can climb from the cervix into the uterus and fallopian tubes, causing pelvic inflammatory disease.

The CDC's fact sheet puts PID in about 10 to 15 percent of women with untreated chlamydia, and the agency's case definition notes that in up to 40 percent of untreated women the infection spreads into the uterus or tubes. PID can permanently scar the tubes, and scarred tubes mean chronic pelvic pain, ectopic pregnancy, or infertility. Repeat infections stack the risk. The research estimate is a tubal factor infertility risk of up to about 6.9 percent after a single chlamydia-caused episode of PID, and it climbs with repeat infections.

None of that is meant to scare you. Chlamydia is curable, and early treatment prevents the damage. But it explains why doctors screen for a germ that never introduced itself: finding it is the only way to stop what you cannot feel.

A history test, not a right-now test: why the distinction matters

Here is where most of the confusion lives, so let us walk through it slowly.

Antibodies are not real-time sensors. IgG in particular is designed to linger. After an infection clears, whether on its own or with treatment, IgG levels fall gradually but can stay detectable for years. A study in the Journal of Infectious Diseases found chlamydia-specific IgG antibodies persisting more than a decade after infection. Your blood remembers what your body forgot.

This means a reactive IgG result is compatible with several completely different realities:

• You had chlamydia years ago, it was treated, and the antibodies are leftovers.

• You had it years ago and never knew, and it cleared on its own.

• You had it more than once, and the result reflects the cumulative exposure.

• You have an active infection right now and the antibodies are part of the response.

The test cannot tell these apart. That is not a flaw in the test. It is simply what serology is: a record of exposure, not a snapshot of the present. Which is exactly why doctors never use this test to diagnose a current infection, and why you should not use it that way either.

The one thing this blood test will never tell you

Guidelines are unusually blunt on this point, and you deserve to hear them directly.

The CDC's laboratory recommendations state that serology has little, if any, value in testing for uncomplicated genital chlamydia infection, and it should not be used for screening, because past infections leave long-lasting antibodies that cannot be easily distinguished from the antibodies of a current one. A review of laboratory diagnosis in the medical literature puts it even more plainly: serum specimens are not recommended for diagnosing acute chlamydia infections.

The test that does diagnose active infection is NAAT, nucleic acid amplification testing, which most people know as PCR. It amplifies the bacteria's own genetic material from a sample, so a positive means the organism is actually there. For women, vaginal swabs are the preferred specimen for NAAT, with first-void urine as an accepted alternative. That is the answer test. The blood test is the history test. They serve different jobs, and mixing them up is where the anxiety comes from. A PCR taken too soon after treatment can still pick up dead bacterial DNA, by the way, which is why doctors time follow-up PCRs rather than rushing them.

There are exactly two situations where chlamydia serology earns its keep, and the same laboratory review names both: chlamydial pneumonia in newborns (where IgM helps) and chlamydial tubal factor infertility (where high IgG helps). Notice what both have in common: neither is about diagnosing a routine genital infection in an adult. One is a baby with pneumonia; the other is a fertility investigation. If your chit is fertility-related, you are looking at the second exception. More on that below.

One practical consequence: a reactive IgG result is never, by itself, a reason to conclude you need treatment today. Treatment decisions belong to your doctor, who reads the result against your symptoms, history, and often a PCR result. That is what the follow-up appointment is for.

IgG, IgM, IgA and PCR: the family on the test menu

Lab catalogs list a small family of chlamydia antibody tests, and their names blur together. It helps to meet them one at a time.

IgG is the one on your report. It looks for past exposure, because IgG antibodies show up after the immune system has had time to build its full response and then stick around for years.

The Anti Chlamydia trachomatis Antibody IgM test looks for recent infection, because IgM antibodies show up early, though for genital chlamydia doctors rely on a PCR test rather than serology to diagnose an active infection. IgM rises fast and falls fast, which makes it a marker of recency, not a diagnosis of current disease. Its one well-established clinical role is in newborns, where high IgM helps diagnose chlamydial pneumonia.

The IgA antibody version sits somewhere in between and is sometimes used when doctors suspect a deeper or longer-running infection. The evidence base here is thinner than for IgG and IgM, so doctors interpret it with caution.

And then there is the Chlamydia DNA test by PCR, usually on a urine sample. This one does not measure antibodies at all. It hunts for the bacteria's genetic material directly, which is what doctors reach for when they need to know whether the infection is active today. If your doctor says "let us confirm with a PCR," this is the confirmation they mean.

Keeping these straight is genuinely useful, because a chit sometimes carries more than one of them. Now you know which question each one answers.

Reading your report line like a lab tech

Your report will say something close to "Reactive" or "Non-reactive." Some labs say Positive or Negative. Some add an index value, an optical density ratio, or a titre like 1:64. Here is how to read each piece without spiraling.

Non-reactive means the lab found no significant IgG antibodies. That suggests no meaningful past exposure, with one caveat: in the first couple of weeks after an infection, antibodies may not have built up yet. Timing matters, and your doctor knows this.

Reactive means antibodies were found. It proves exposure, not active infection, not infertility, not anything else on its own.

If there is a number, your doctor compares it against that specific lab's own cut-off. Cut-offs differ from one laboratory to another, and from one assay kit to another, so one lab's index is not directly comparable to another's. Do not line your number up against a friend's report, a forum post, or a number you saw online. The words Reactive and Non-reactive are the meaningful part. The number is a tool for the lab, not a score.

A reactive result is one data point. It needs the rest of your file before it means anything. Your doctor may follow it with a urine PCR test to check for an active infection, or simply a conversation about what comes next. Do not read the report alone at midnight and spiral. Take it to the doctor who ordered it; they have the rest of your file, and that is the only context in which the result means anything.

Some reports add a third word to the mix: Equivocal, or Borderline, sometimes Grey Zone. That means the measured signal fell between the lab's negative and positive cut-offs, too weak to call either way. It is not a maybe-infection. It is a measurement shrug, and the usual answer is a repeat draw after a few weeks, or the PCR test if your doctor wants today's answer sooner. If you get an equivocal result, the only wrong move is treating it as a diagnosis in either direction.

Why doctors order this blood test anyway

This is the question patients actually ask at our counter in Malad, usually with the chit in one hand: "If this test cannot tell me I have it now, why did my doctor order it?" It is a fair question, and there is a good answer.

The answer is fertility. Tubal factor infertility, where the fallopian tubes are blocked or damaged, accounts for roughly 10 to 30 percent of infertility cases, and chlamydia is the most common infectious cause of it. The silent scarring described earlier is exactly what fertility specialists are hunting for. When a couple has been trying to conceive without success, or when a doctor is screening before fertility treatment, a Chlamydia IgG result helps answer a narrower question: has this patient's immune system ever tangled with chlamydia badly enough to leave antibodies behind?

The research backs the practice. In studies of women with tubal infertility, the share with positive chlamydia IgG runs around 30 to 46 percent, compared with about 6 to 12 percent in comparison groups. One large fertility-center study found tubal blockage on imaging in 39 percent of seropositive women versus about 10 percent of seronegatives, and women with a positive serology were far more likely to end up needing IVF to conceive. The antibodies persist so long that they function as a record of the infections that could have done the scarring.

Notice what the doctor is doing. They are not asking "is she infected today." They are asking "is there a past infection in her history that could explain blocked tubes." The IgG test is one of the few non-invasive ways to ask that. The definitive answer still comes from imaging or laparoscopy, but the blood test helps the doctor decide whether to look harder.

It also helps to know what the usual follow-up path looks like, so a reactive result does not feel like a dead end. If the IgG comes back reactive in a fertility workup, the next step is typically imaging of the tubes, often a hysterosalpingogram, or a camera look called laparoscopy if the doctor wants a direct view. These are the tests that actually see blockage or scarring. The blood test is the reason to look; the imaging is the looking.

One hard truth sits underneath all of this, and your doctor will not hide it from you: once fallopian tubes are scarred, antibiotics cannot unscar them. Treatment clears the infection, and clearing it early is what prevents the damage in the first place. That is why every guideline pushes early detection so hard, and why a reactive IgG in a fertility workup is treated as a prompt to investigate now rather than later. The good news is that blocked or damaged tubes are not the end of the road. Fertility medicine has a whole second playbook, including IVF, which in the large fertility-center study produced equivalent pregnancy rates for seropositive and seronegative women. The path may be longer. It is not closed.

Nobody is accusing anyone of anything by ordering it. Doctors put this test on the chit the same way they put thyroid tests or sugar tests on it: they are ruling things in and out. If you are reading this with a fertility-related chit in your hand, that context is almost certainly why the test is there. Chlamydia IgG sits on fertility chits beside hormone markers like beta hCG and AMH, because a fertility workup looks at the whole reproductive picture at once.

Questions people actually ask

Does a reactive Chlamydia IgG mean I have chlamydia right now? Not necessarily. It proves past exposure. Your doctor reads it with your symptoms and history, and may order a PCR test, which looks for the bacteria's genetic material, to check for an active infection. That is the standard test for current chlamydia, per CDC guidance.

Do I need to fast before the test? No. It is a simple blood test with no fasting and no special preparation. It can be drawn at any time of day, and you can eat normally before and after.

How long does the report take? About 24 hours at our lab. You can book it through the test page, which also shows the current price, or call us on 84250 40353. Home collection is available across Malad, Kandivali, Borivali and Goregaon.

Why was this ordered when I feel completely fine? Because chlamydia usually causes no symptoms, which is exactly why it gets screened for, especially in fertility and pregnancy-related workups. Feeling fine does not rule out past exposure, and that is the whole point of the test.

Can a treated infection from years ago still show up? Yes, and this trips people up. IgG antibodies can linger in the blood for years after successful treatment, in some studies more than a decade. Doctors expect this. A reactive result after treatment does not mean the treatment failed.

Should my partner be tested? That is a conversation for your doctor, not a decision the report makes for you. Partner testing and treatment matter when there is an active infection diagnosed by PCR. A reactive IgG on its own does not diagnose one.

My PCR was negative but IgG is reactive. Which do I believe? Both. They answer different questions. A negative PCR says no active infection was detected in that sample today. A reactive IgG says your immune system met the bacteria at some point before. Neither contradicts the other, and your doctor reads them together.

Does a reactive result mean I am infertile? No. It means your doctor has one more reason to check your tubes carefully, usually with imaging. Many people with reactive IgG results conceive without any trouble. The result suggests a line of investigation, not a diagnosis of infertility.

Will I need to repeat this test after treatment? Usually not for monitoring. Since IgG stays positive long after treatment, repeating the IgG test cannot confirm that treatment worked. If your doctor wants to confirm an infection is gone, they use a PCR, timed appropriately after treatment.

The pregnancy connection

Chlamydia screening during pregnancy follows the same logic as fertility screening: catch the silent infection before it causes damage. The WHO lists the stakes plainly. Untreated chlamydia in pregnancy is associated with prematurity and low birth weight, and the infection can pass to the baby during delivery, causing eye infection (conjunctivitis) or pneumonia in the newborn. Chlamydia is one of the leading causes of early infant pneumonia.

Here is an important distinction for anyone reading an antenatal chit. When doctors screen pregnant women for chlamydia, they use NAAT, the PCR-style test on a swab or urine sample, not the IgG blood test. The goal in pregnancy is finding an active infection that needs treatment now, and only NAAT answers that question. If you are pregnant and your chit carries chlamydia testing, it will almost certainly be the swab or urine test, not this blood test.

Our guide to the Ante Natal Panel 1 walks through what the first pregnancy blood panel actually covers, including the HBsAg hepatitis B screen and urine routine and microscopy, which are standard alongside it. The chlamydia IgG blood test belongs more to the fertility-workup world than to the antenatal world. If it landed on your chit during a pregnancy workup, your doctor can tell you which of the two jobs it is doing.

The conversation nobody rehearses

There is a question that almost never gets asked at the counter, because it is asked later, at home, in a quieter voice. It goes something like: what do I tell my partner?

First, the facts that make this conversation easier than it feels. A reactive IgG result does not say when the exposure happened. It could have been years ago, before this relationship existed. It does not say the exposure is still an infection. And it does not point at anyone. Antibodies are a record without a timestamp, and anyone who has ever been sexually active can carry them. Your doctor knows all of this, and any conversation with a partner should start from the same facts, not from guilt or accusation.

Second, the practical part. Partner testing and treatment genuinely matter, but they matter when an active infection has been diagnosed, which happens through PCR, not through this blood test. If your doctor follows up with a PCR and it comes back positive, that is when both partners get tested and treated, and when your doctor talks through the timing: treatment, then waiting, then a follow-up check, with no intercourse in between. If the PCR is negative, the conversation is a different one, mostly about reassurance and record-keeping.

None of this needs to happen tonight. Read the result, sleep on it, and bring it to the appointment. The appointment is where facts replace fear.

The practical half: the blood draw itself

There is nothing to prepare for. No fasting, no special timing, no water restriction. The phlebotomist ties the rubber tourniquet around your upper arm, swabs a cold patch of alcohol on the inside of your elbow, and asks you to make a fist. The needle goes in with a sharp little pinch that lasts about two seconds. The vial fills fast, one small tube, and then comes the familiar cotton ball pressed to the spot and a strip of tape over it. It stings for a second, and then it is over. The whole event takes less time than the billing queue did. Occasionally the spot blooms into a small bruise the next day. It fades within a few days and means nothing about the result.

If you book home collection, it happens the same way on your own sofa: the search for the vein, the pinch, the cotton ball. Book on 84250 40353 and pick a late-evening or early-morning slot if that suits you better; the lab runs 24x7 from Malad, and home collection across Malad, Kandivali, Borivali and Goregaon is free.

Reports land in about 24 hours. For the current price, check the test page directly, since prices change and a linked page stays current in a way this article cannot.

One small tip from the counter: if your chit has several tests on it, ask for all of them in one draw. Most chit-mates, including the thyroid profile, draw from the same vial, so there is rarely a reason to get stuck twice.

Doctors rarely order this one alone. When it appears on a fertility chit, it usually sits beside hormone tests and other screening markers, and the Female Fertility Panel - Basic or the Women's Fertility & Hormone Panel wrap several of these markers into one booking. That is worth knowing if you are staring at a long chit and wondering how many separate visits it will take. The answer is usually one.

The pattern is worth understanding. A fertility workup is not one test but a panel of them, each ruling something out. The IgG test contributes the infection-history piece. The hormone markers contribute the ovulation and ovarian-reserve pieces. Read together, they give your doctor the map. Read alone, each one is just a fragment, which is another reason the report belongs back with the doctor who ordered it.

If you are not sure what to book next, browse the full health packages or the tests page.

Back to the report in your hand

A reactive result changes one thing: your doctor now knows your immune system has encountered chlamydia at some point. In a fertility context that is a genuine lead, usually followed with imaging or a closer look at the tubes.

It does not diagnose an active infection. It does not date the exposure. It does not say whether treatment is needed today, and it does not predict infertility. Nothing about it requires action before your next appointment except bringing the report along.

Read it as a footnote your immune system left behind, one your doctor now gets to read with the rest of the file. That is what the test was ordered for.

References

• World Health Organization, Chlamydia fact sheet: global burden of 128.5 million new infections in 2020, complications including PID and infertility, adverse pregnancy outcomes.

• CDC, Recommendations for the Laboratory-Based Detection of Chlamydia trachomatis and Neisseria gonorrhoeae (2014): NAAT as preferred diagnostic test; serology has little value for uncomplicated genital chlamydia infection.

• CDC, Chlamydia fact sheet: PID in about 10 to 15 percent of women with untreated chlamydia; permanent fallopian tube damage and infertility risk.

• CDC, Chlamydia Trachomatis Infection 2022 Case Definition: asymptomatic rates and symptom timing.

• The laboratory diagnosis of Chlamydia trachomatis infections (peer-reviewed review): serum not recommended for acute diagnosis; serology exceptions are chlamydial neonatal pneumonia (IgM) and tubal factor infertility (IgG).

• Journal of Infectious Diseases 2025, Serum IgG1 and IgG3 antibody responses in tubal factor infertility: Pgp3 IgG association with TFI, antibody persistence beyond 10 years, TFI risk up to 6.9 percent after one chlamydia-caused PID episode.